Literature DB >> 9036740

Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB).

C P Cannon1, C H McCabe, P H Stone, M Schactman, B Thompson, P Theroux, R S Gibson, T Feldman, N S Kleiman, G H Tofler, J E Muller, B R Chaitman, E Braunwald.   

Abstract

Circadian variation has been demonstrated in several types of acute cardiovascular disease, including acute myocardial infarction (AMI), sudden cardiac death, silent ambulatory ischemia, and thrombotic stroke. In contrast, no diurnal variation was observed in 1 study of non-Q-wave AMI, and limited data are available for unstable angina. To assess whether circadian variation is present in unstable angina and non-Q-wave AMI, we examined the time of onset of ischemic pain in 7,731 patients who were prospectively identified in the Thrombolysis in Myocardial Ischemia (TIMI) III Registry, 3,318 of whom were enrolled in the prospective study, and in 1,473 patients enrolled in the TIMI IIIB trial. A circadian variation in the onset of pain was observed, with an increase in the number of patients experiencing the onset of pain in the morning hours between 6 A.M. and 12 noon (p <0.001). This circadian variation was observed both in patients with unstable angina and in those with evolving non-Q-wave AMI. A similar circadian pattern was observed in all subgroups tested. These findings were confirmed in the TIMI IIIB trial and complement previous studies suggesting that circadian variation exists in the onset of the full spectrum of myocardial ischemic syndromes.

Entities:  

Mesh:

Year:  1997        PMID: 9036740     DOI: 10.1016/s0002-9149(97)00743-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Endogenous circadian rhythm in an index of cardiac vulnerability independent of changes in behavior.

Authors:  Kun Hu; Plamen Ch Ivanov; Michael F Hilton; Zhi Chen; R Timothy Ayers; H Eugene Stanley; Steven A Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

2.  Circadian variation in witnessed out of hospital cardiac arrest.

Authors:  L H Soo; D Gray; T Young; J R Hampton
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 3.  The impact of the circadian timing system on cardiovascular and metabolic function.

Authors:  Christopher J Morris; Jessica N Yang; Frank A J L Scheer
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 4.  Complexities in cardiovascular rhythmicity: perspectives on circadian normality, ageing and disease.

Authors:  Oliver Monfredi; Edward G Lakatta
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

5.  Impact of the human circadian system, exercise, and their interaction on cardiovascular function.

Authors:  Frank A J L Scheer; Kun Hu; Heather Evoniuk; Erin E Kelly; Atul Malhotra; Michael F Hilton; Steven A Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 6.  Chronopharmacokinetics of ciclosporin and tacrolimus.

Authors:  Massimo Baraldo; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 7.  Circadian clock genes and implications for intestinal nutrient uptake.

Authors:  Anita Balakrishnan; Ali Tavakkolizadeh; David B Rhoads
Journal:  J Nutr Biochem       Date:  2012-03-13       Impact factor: 6.048

Review 8.  Visceral chest pain in unstable angina pectoris and effects of transcutaneous electrical nerve stimulation. (TENS). A review.

Authors:  M Börjesson
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

9.  Sleep-induced hypotension precipitates severe myocardial ischemia.

Authors:  Song-Jung Kim; Alex Kuklov; Richard F Kehoe; George J Crystal
Journal:  Sleep       Date:  2008-09       Impact factor: 5.849

Review 10.  Circadian clock and the onset of cardiovascular events.

Authors:  Norihiko Takeda; Koji Maemura
Journal:  Hypertens Res       Date:  2016-02-18       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.